NCT04569747
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer treatment 2 recruiting NCT00477100
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients with Inflammatory or Invasive Breast Cancer No drug interventions Not Available Not Available recruiting NCT00601900
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer treatment 3 active_not_recruiting NCT01272037
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer treatment 3 active_not_recruiting NCT02876107
Carboplatin and Paclitaxel with or Without Panitumumab in Treating Patients with Invasive Triple Negative Breast Cancer treatment 2 active_not_recruiting NCT02954874
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer treatment 3 active_not_recruiting NCT03359954
Radiation Therapy Before Surgery in Treating Patients with Hormone Receptor Positive, HER2 Negative Breast Cancer No drug interventions treatment 2 active_not_recruiting NCT02779855
Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer treatment 1 / 2 active_not_recruiting NCT04521764
A Vaccine (MV-s-NAP) for the Treatment of Patients with Invasive Metastatic Breast Cancer treatment 1 recruiting NCT04959474
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer No drug interventions supportive_care Not Available recruiting NCT05327608
Intermittent Fasting for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery No drug interventions supportive_care Not Available suspended NCT05406232
Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer No drug interventions Not Available Not Available recruiting NCT02856503
Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors treatment 1 / 2 withdrawn NCT01434303
Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab Only treatment 1 completed NCT02945579
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy No drug interventions treatment Not Available recruiting NCT02370277
Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer No drug interventions Not Available Not Available completed NCT02282345
Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer treatment 2 completed NCT05036083
Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion diagnostic Not Available completed NCT05710328
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial No drug interventions diagnostic 2 recruiting NCT04139993
RBX7455 Before Surgery for the Treatment of Operable Breast Cancer No drug interventions treatment 1 terminated NCT04897009
Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer No drug interventions Not Available Not Available active_not_recruiting NCT03971409
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer treatment 2 recruiting NCT02860000
Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer treatment 2 active_not_recruiting NCT03679559
Exercise in Improving Health and Quality of Life in Breast Cancer Survivors No drug interventions supportive_care Not Available completed NCT04169542
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery No drug interventions Not Available Not Available recruiting NCT04266249
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy treatment 2 recruiting NCT04481113
Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer treatment 1 active_not_recruiting NCT03128619
Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer treatment 1 terminated NCT03077841
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer No drug interventions treatment 2 / 3 active_not_recruiting NCT04871516
Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer No drug interventions treatment Not Available recruiting NCT02456857
Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative treatment 2 completed NCT04087057
Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast Cancer No drug interventions Not Available Not Available completed NCT02918474
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer No drug interventions supportive_care Not Available recruiting NCT02453620
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer treatment 1 active_not_recruiting NCT03345420
Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer No drug interventions treatment 2 active_not_recruiting NCT00148720
Capecitabine in Women With Operable Breast Cancer treatment 2 terminated NCT05319873
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer treatment 1 / 2 recruiting NCT01750073
Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer treatment 2 active_not_recruiting NCT03796273
Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases treatment 0 terminated NCT05012176
An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors No drug interventions supportive_care Not Available active_not_recruiting NCT02445391
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy treatment 3 active_not_recruiting NCT01846091
Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast Cancer treatment 1 completed NCT02883062
Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer treatment 2 completed NCT03454529
The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer treatment 2 completed NCT04001829
Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer supportive_care 2 active_not_recruiting NCT02530489
Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer treatment 2 active_not_recruiting NCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation No drug interventions Not Available Not Available recruiting NCT05023967
Metformin and Nightly Fasting in Women With Early Breast Cancer prevention 2 recruiting NCT02957968
Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca treatment 2 active_not_recruiting NCT02912312
Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer No drug interventions treatment 2 recruiting NCT01245712
Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer No drug interventions treatment 2 active_not_recruiting NCT02515110
Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer No drug interventions treatment Not Available active_not_recruiting NCT05447910
Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer health_services_research 2 completed NCT03737695
Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer No drug interventions Not Available Not Available suspended NCT05545150
Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study No drug interventions diagnostic 2 recruiting NCT01753908
Broccoli Sprout Extract in Treating Patients With Breast Cancer No drug interventions basic_science 0 completed NCT02276443
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative No drug interventions treatment Not Available recruiting NCT03238703
Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer treatment 4 withdrawn NCT05786664
Breast Cancer Survivorship Biorepository No drug interventions Not Available Not Available recruiting NCT01334021
Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer No drug interventions diagnostic 2 active_not_recruiting NCT05071677
Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer No drug interventions Not Available Not Available completed NCT03789877
A Home-Based Walking Program and rTMS in Helping Breast Cancer Survivors Get More Physical Activity No drug interventions supportive_care Not Available completed NCT02526498
Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery No drug interventions treatment 2 completed NCT03188393
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery No drug interventions other 2 suspended NCT00877500
Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy treatment 2 active_not_recruiting NCT03414970
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer No drug interventions supportive_care 3 active_not_recruiting NCT04379570
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy No drug interventions health_services_research 3 recruiting NCT03518242
Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer treatment 1 completed NCT01266642
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer No drug interventions treatment 2 active_not_recruiting NCT01964924
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer treatment 2 completed NCT04647916
Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases treatment 2 recruiting NCT05177796
Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer treatment 2 withdrawn NCT04457596
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial treatment 3 recruiting NCT03323658
Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer prevention 1 completed NCT04294225
Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer treatment 2 completed NCT00429182
Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer treatment 2 completed NCT01344031
MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer treatment 1 completed NCT05340673
Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer No drug interventions supportive_care 1 recruiting NCT02689427
Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer treatment 2 completed NCT02037529
Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer treatment 3 suspended NCT03554044
T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer treatment 1 active_not_recruiting NCT04009044
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast treatment 2 recruiting NCT02876640
Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer prevention 1 terminated NCT03606967
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer treatment 2 recruiting NCT04022772
Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer No drug interventions supportive_care Not Available completed NCT01622868
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer treatment 2 completed NCT05334069
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection No drug interventions Not Available Not Available recruiting NCT05464810
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer treatment 0 recruiting NCT04667481
Adaptive Training Exercise Programs for Improving Cardiorespiratory Fitness After Breast Cancer Treatment, The ACTIVATE Trial No drug interventions supportive_care Not Available completed NCT01849250
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors prevention 2 completed NCT03979508
Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer treatment 2 recruiting